Dr. Chai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204Phone+1 980-442-2000
Summary
- Dr. Seungjean Chai is an oncologist in Charlotte, NC and is affiliated with multiple hospitals in the area, including Atrium Health's Carolinas Medical Center and Atrium Health's Carolinas Medical Center. He received his medical degree from Medical College of Georgia School of Medicine and has been in practice 19 years. He specializes in breast cancer and gastrointestinal cancer.
Education & Training
- University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- University of Virginia Medical CenterResidency, Internal Medicine, 1998 - 2001
- Medical College of Georgia at Augusta UniversityClass of 1998
Certifications & Licensure
- NC State Medical License 2004 - 2024
- VA State Medical License 1998 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Regorafenib in Advanced Pancreatic Cancer Patients Start of enrollment: 2014 Jun 06
Publications & Presentations
PubMed
- 20 citationsLevine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging ProblemDerek Raghavan, Nicole A. Keith, Hughes R. Warden, Seungjean Chai, Wendy Jo Turan
JCO Oncology Practice. 2021-06-08 - 204 citationsFirst-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and ...Harpreet Wasan, Peter Gibbs, Navesh K Sharma, Julien Taieb, Volker Heinemann
The Lancet. Oncology. 2017-09-01 - 32 citationsSunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT - 3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) S...Tareq Al Baghdadi, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat, Patricia Rich
Targeted Oncology. 2020-10-17
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: